Evaluation of the effect of oral ritodrine on implantation rate of in vitro fertilization – embryo transfer cycles
Not Applicable
- Conditions
- infertility.Female Infertility
- Registration Number
- IRCT201301146868N5
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
women having a normal uterus assessed with hysterosonography or hysteroscopy; infertility due to factors pipe; infertility due to male factor unexplained. Exclusion criteria: women having a systemic diseases; infertility due to advanced pelvic endometriosis; having endometriomas greater than 2 cm.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Successful implantation. Timepoint: Two weeks after embryo transfer. Method of measurement: Increased hormone levels in the blood ßHCG.
- Secondary Outcome Measures
Name Time Method The number and quality of oocytes and embryos, embryo transfer quality and results ßHCG. Timepoint: Two weeks after embryo transfer. Method of measurement: Increased ßHCG.